B12 Metabolism and Multiple Sclerosis.
- 1 January 1960
- journal article
- research article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 103 (1), 180-183
- https://doi.org/10.3181/00379727-103-25451
Abstract
The serum vitamin B12 and glutathione levels in red cells were determined in patients with multiple sclerosis (M.S.). Both substances were found to be reduced in M.S. patients as compared to normal subjects. Following intramuscular injection of vitamin B12, M.S. subjects showed reduced ability to retain the vitamin. They did absorb it adequately when taken orally. A vitamin B12-tannate derivative was found to be excreted more slowly by M.S. patients than aqueous vitamin B12.Keywords
This publication has 13 references indexed in Scilit:
- Vitamin B-12 in neuro-metabolism (preliminary clinical report)Digestive Diseases and Sciences, 1955
- Vitamin B12 Serum Levels and Diabetic Retinopathy.Experimental Biology and Medicine, 1954
- Serum Concentrations of Vitamin B12 in Patients Suffering from LeukemiaBlood, 1954
- VITAMIN B12Excretion and DIABETIC RETINOPATHYThe American Journal of Clinical Nutrition, 1953
- THE EFFECT OF VITAMIN B12 ON THE LEVELS OF SOLUBLE SULFHYDRYL COMPOUNDS IN BLOODJournal of Biological Chemistry, 1953
- The Vitamin B12 Concentrations of Serum and Urine of Normals and of Patients with Megaloblastic Anaemias and Other DiseasesJournal of Clinical Pathology, 1952
- Retention of Crystalline Vitamin B12 by Healthy Male Individuals Following Intramuscular InjectionJournal of Nutrition, 1952
- Effect of Stress and the Adrenocorticotrophic Hormone on Blood GlutathioneAmerican Journal of Physiology-Legacy Content, 1951
- A MODIFICATION OF THE NITROPRUSSIDE METHOD OF ANALYSIS FOR GLUTATHIONE1951
- THE USE OF LACTOBACILLUS LEICHMANNII IN THE MICROBIOLOGICAL ASSAY OF THE “ANIMAL PROTEIN FACTOR”Journal of Biological Chemistry, 1948